Shows
Cures & CapitalHow Wall Street Really Values Biotech with Hartaj SinghHow do investors really value biotech? Former hedge fund investor and biotech analyst Hartaj Singh explains how Wall Street thinks about risk, biology, clinical trials, and uncertainty - and why biotech valuation is both art and formula.Hartaj Singh on LinkedIn:https://www.linkedin.com/in/hartaj-s-35614670/Check out Hartaj's newsletter:The Biotech Capital Compass - https://hartajsingh1.substack.com/Subscribe to the Cures & Capital podcast on YouTube, Apple Podcasts, and Spotify!Make sure to follow us on LinkedIn:...
2025-12-181h 26Cures & CapitalAdvanced Drug Modalities with Jeff Holder & Adam Siebert: From Science to Real-World ImpactIn this episode, we talk to Jeff Holder and Adam Siebert, Partners and Managing Directors at L.E.K. Consulting, about the rapidly evolving world of advanced drug modalities. With years of experience advising clients across the life sciences industry, Jeff and Adam sit at the intersection of cutting-edge science and the real-world constraints of getting medicines to patients. Together, we unpack the past, present and future of advanced drug modalities, the science and the strategic implications behind them, and explore what it really takes to bring these breakthroughs to market.If you want to c...
2025-11-261h 06
Daytime ConfidentialWho's the Daddy?On episode 1186 of Daytime Confidential, Luke Kerr, Jillian Bowe, Joshua Baldwin and Melodie Aikels dish the latest Beyond the Gates, The Bold and the Beautiful, Days of Our Lives, General Hospital and The Young and the Restless headlines and storylines. BEYOND THE GATES Andre chooses Dani over Ashley. Martin has a self-righteous meltdown over his daughter's "Magnum" scandal. Kat doesn't deserve the blame, and Eva calling Ted "Dad" sets her off. Luke predicts Izaiah will turn out to be Joey's son. THE BOLD AND THE BEAUTIFUL Taylor and Deacon's chemistry is undeniable, and Sheila senses...
2025-11-091h 13Cures & CapitalSheila Gujrathi, MD: How to elevate female leaders and underrepresented voices in biopharmaIn this episode of Cures & Capital, Dr. Sheila Gujrathi — biotech entrepreneur, investor, and former CEO of Gossamer Bio — shares her perspective on how to elevate female leaders and underrepresented voices in biopharma.She discusses lessons from her 25+ years leading companies and investments, and why inclusive leadership is key to innovation and value creation.We also dive into her book, The Mirror Effect, and her mission to inspire the next generation of women in biotech.Check out Sheila's book (released Nov. 4, 2025) on her website:https://sheilagujrathimd.com/book/ 🎙️...
2025-11-051h 00
Soap Opera News - DailySoap Opera Showdown: Dramatic Revivals, Family Secrets, and Scandalous Returns Shake Up Daytime TelevisionListeners, hold on to your martinis and slide into your silk robes because daytime drama is hitting peak fabulous on this sizzling Sunday, November 2, 2025. The stars are aligning for the soap opera elite, and your favorite icons are making jaw-dropping returns, scandalous new arrivals, and enough twists to rattle the chandeliers in any mansion from Genoa City to Salem.Let’s start in Genoa City where The Young and the Restless is serving a high society shake-up as Lucas Adams officially steps into the shoes of Noah Newman, and the family drama is as thick as caviar on to...
2025-11-0204 min
Hosť DRSPali Slezák, Erika Zámečníková, Monika Schieberová, Vanesa Hocková, Martin Horváth, Zuzana Straková Wenzlová, Viliam Stankay (24.10.2025 08:21)Ďalší finalista, ktorý opustil pekársku šou Pečie celé Slovensko Pali, ktorý je povestný svojimi neodolateľnými pagáčikmi. Celým menom Pavol Slezák v rozhovore povie aj to, ako sa učil piecť a čo ho fascinuje na včelárstve. Vedúca sestra Centra špecializovaných ambulancií Erika Zámečníková z Onkologického ústavu sv. Alžbety predstaví Ružový október. Logopedička Monika Schieberová poradí rodičom, v akom veku sa prejavujú prvé problémy zajakavosti a čo ju spôsobuje. Strelkyňa Vanesa Hocková a strelec Martin Horváth priblížia, čo je to skeet, ako sa k tejto streleckej disc...
2025-10-2443 minCures & CapitalScott Berry on Rethinking Clinical Trials: Bayesian Design, Adaptivity, and Smarter DecisionsIn this episode, we talk to Scott Berry, President and Senior Statistical Scientist at Berry Consultants - a pioneer in adaptive and Bayesian clinical trial design. With more than 25 years of experience designing trials for pharma, biotech, and government agencies, Scott has helped reshape how we think about learning in drug development.We explore what it really means to “learn as you go” in clinical trials - from the limitations of the traditional frequentist model to the promise of adaptive and Bayesian designs that evolve with the data. Scott breaks down why these methods can de-risk programs, opti...
2025-10-151h 19Soap Opera News - DailySoap Opera Roundup: Bold and Beautiful, Beyond the Gates Serve Dramatic Love Triangles and Unexpected Twists This WeekListeners, clear your schedules and pour a little extra champagne—today, America's top daytime dramas are serving up more glitz, intrigue, and heartbreak than the Met Gala afterparty. On the Bold and the Beautiful, everyone’s talking about Hope Logan, who is torn between two very eligible bachelors: her loyal fiancé Carter and her eternally swoon-worthy ex-husband Liam. Hope’s heart may be divided, but the real showstopper today is the pure delight in Beth Spencer’s eyes as she practices a heartwarming father-daughter dance with Liam, who’s holding onto family tighter than a diamond choker at a Beverly Hills ball...
2025-09-3002 minSoap Opera News - DailySoap Opera Spectacular: Shocking Returns, Steamy Secrets, and Family Drama Ignite Daytime Television This WeekListeners, welcome to the ultimate swirl of glamour, secrets, and seduction straight from daytime’s richest and most outrageous worlds. This Monday, September 29, 2025, serves up sensational surprises and jaw-dropping homecomings, so let’s plunge into the velvet-draped lives of America’s top soap opera stars.On Days of our Lives, our Salem aristocrats turn up the heat—literally and figuratively! Belle and EJ are trapped in an elevator, sparking wickedly delicious tension, while poor Holly finds herself surrounded by flames. Will heroics reign or will drama sizzle the day away? Chad and Cat wrap themselves up in romance, sharing...
2025-09-2903 min
Eshopy za pochoduProdal ESHOP ZA STOVKY MILIONŮ | Co radí? | ROZHOVOR Martin BernátekHostem podcastu je Martin Bernátek - zakladatele Ovečkárny, kterou úspěšně prodal. Dnes Martin buduje nový eshop OlaOla prodávající suplementy a další produkty z oblasti dlouhověkosti a longevity.Pokud jsi eshopař nebo člověk z online marketingu, pak tě tenhle díl bude bavit.Probrali jsme všechno: jak přenést know-how z úspěšného e-shopu do nového byznysu, jak nastavit brand, co dává smysl outsourcovat, ale i to, proč není dobré vlastnit sklad.Uslyšíš taky, jak Martin pracuje s influenc...
2025-09-111h 10Cures & CapitalDeborah Dunsire on leading in today’s biopharma landscapeIn this episode, we talk to Deborah Dunsire, board chair at Neurvati Neurosciences, multiple times board member, and a former CEO of Lundbeck. With more than 3 decades of experience, Deborah has navigated organizations of every size through change, uncertainty, and opportunity.We explore what it takes to lead in today’s biopharma landscape - from rolling up your sleeves in biotech to streamlining decisions in big pharma, and from balancing short-term survival in a capital-constrained environment to laying the groundwork for long-term innovation. Deborah also shares insights on the interplay between boards and executive teams, the pitfalls of...
2025-08-271h 04
Tuesday HometimeRecent Freedom Flotilla experience | Albanese's missed opportunities towards Australia's Independence | Life's work, activism of Bob Phelps | Justice + free speech in a decent society?His Week That Was – Kevin Healy, Human rights activist Robert Martin and his experiences on the Freedom Flotilla vessel to Gaza and then prison in Israel, Dr Alison Broinowski and 11 opportunities for Albanase to ensure Australia’s independence, Lifelong work of activist for peace and a just society Bob Phelps, and Associate Professor Peter Slezak looking at the issue of truth, justice and free speech in a decent society. Head to www.3cr.org.au/hometime-tuesday for full access to links and previous podcasts
2025-08-1900 min
BizNexus RoundupWarren Buffets reflections on M&AThe provided text offers Warren Buffett's 2019 reflections on mergers and acquisitions (M&A), originally shared in a Berkshire Hathaway letter to shareholders. Buffett emphasizes that even initially promising deals can falter, likening acquisitions to marriages where pre-nuptial expectations often differ from reality.He advises rigorous evaluation over romanticized views during corporate courtships, as buyers frequently encounter unforeseen challenges. Finally, Buffett suggests that spreading investments across various businesses allows successful ventures to grow and absorb more capital over time, ultimately improving overall returns. The text also includes a brief...
2025-08-0412 minCures & CapitalDr. Andrée Bates on AI that works: from pilot chaos to real impactIn this episode, we talk to Dr. Andrée Bates, founder and CEO of Eularis, a company helping clients accelerate pharma business results through Artificial Intelligence.We explore how the biopharma industry can move beyond scattered pilots toward strategic, enterprise-wide AI integration. Drawing on decades at the forefront of AI in pharma, Dr. Bates shares practical insights on building the foundations for long-term value creation and turning AI into a true competitive advantage. We also dig into how to calculate ROI on AI, avoid the “spray and pray” trap, and why the future of pharm...
2025-06-261h 18Cures & CapitalLeon 'Jun' Tang: Inside the Rise of China's Biotech IndustryHow did China become a serious force in global biotech in just over a decade?This is the insider story of China's biotech boom!Dr. Leon 'Jun' Tang, founding partner of InScienceWeTrust BioAdvisory, joins Cures & Capital to unpack the rise of Chinese biopharma.From talent migration and government planning to innovation in ADCs and the challenges of commercialization.Chapters00:00 - Introduction & Leon’s global background01:13 - Guest introduction - Leon 'Jun' Tang05:35 - Impact of Chinese biotech innovation at biomedical conferences...
2025-06-101h 18Cures & CapitalJason O'Neill on cracking the code to successful drug launches - Part 2In this episode, we talk to Jason O’Neill, former CEO of Dendreon and Iridium Therapeutics, and author of The Secrets of Successful Drug Launches.This conversation is a practical guide to new drug launches, packed with Jason's hard-won insights. We explore why so many launches fail, the psychology behind adoption resistance, what meaningful relative advantage really means, how to plan for a successful launch, and when you actually need to start thinking about commercialization.This episode will shift how you think about launching new drugs, and what it truly takes to do it successfully....
2025-05-2852 minCures & CapitalJason O'Neill on cracking the code to successful drug launches - Part 1In this episode, we talk to Jason O’Neill, former CEO of Dendreon and Iridium Therapeutics, and author of The Secrets of Successful Drug Launches.This conversation is a practical guide to new drug launches, packed with Jason's hard-won insights. We explore why so many launches fail, the psychology behind adoption resistance, what meaningful relative advantage really means, how to plan for a successful launch, and when you actually need to start thinking about commercialization.This episode will shift how you think about launching new drugs, and what it truly takes to do it successfully....
2025-05-2142 minCures & CapitalEpisode 9 - Reflections and TakeawaysOver the past few months, we’ve had the chance to speak with some of the sharpest minds in the industry—thinkers and practitioners who have shaped how we understand drug innovation, R&D productivity, portfolio strategy, and other critical topics.In this episode, we bring together the major insights and lessons, highlighting patterns that emerged across the different conversations.We also spotlight the unique takeaways from each guest to help ensure these key learnings really stick. Whether you're an R&D leader, investor, innovator, or strategist, these insights will help you rethink how to crea...
2025-05-0733 minCures & CapitalAaron Schacht on the pharmaceutical industry's grand challenge and managing R&D at scaleIn this episode, we talk to Aaron Schact, the CEO and Board Director at BiomEdit and former R&D leader at Eli Lilly and Elanco. We discuss how to improve biopharma's R&D productivity and the industry's "grand challenge", why R&D productivity is the mental model for managing R&D at scale, practical advice on how to approach and work with R&D productivity, and much more!If you want to connect with us - we would love to hear from you:Linkedin: https://www.linkedin.com/company/cures-capital-podcastIf you p...
2025-04-2253 minCures & CapitalMatthias Krings on crafting winning biopharma strategies and smart decisionsIn this episode, our guest is Dr. Matthias Krings - a senior partner at Catenion, a biopharma strategy consulting firm.Matthias is a seasoned veteran in biopharma strategy.In this conversation, he shares his playbook for achieving success as a biopharma company.As critical pillars for biopharma success, we dive into strategy processes, decision-making, and effective R&D risk management.If you want to connect with us - we would love to hear from you:LinkedIn: https://www.linkedin.com/company/cures-capital-podcastYou can also watch the...
2025-04-0749 minCures & CapitalStephan Christgau on applying the VC mindset in biotech & pharmaHow do venture capitalists think? And how do they define and create value in the life science industry?In this episode, we talk to Stephan Christgau, founding partner of Eir Ventures, about the VC mindset, investment decision-making and portfolio strategy. We dive into how VCs assess risk, balance high-stakes opportunities, and what could pharma and biotech companies learn from the VC way of doing things.If you want to connect with us - we would love to hear from you:Linkedin: https://www.linkedin.com/company/cures-capital-podcastIf you prefer to get...
2025-03-201h 03Cures & CapitalMurray Aitken's guide to biotech & pharma leaders: Navigating great uncertainty and complexityIn this episode, we sit down with Murray Aitken, Executive Director of the IQVIA Institute for Human Data Science, to discuss the trends shaping the life sciences industry in 2025 and beyond.How do we navigate the life sciences industry in times of great uncertainty?Murray has observed the life sciences industry for decades and lays out his balanced perspective of the state of the industry and the underlying uncertainties, challenges and opportunities. This episode is a must-watch for anyone who wants to know what is going on in the industry. If you want t...
2025-03-041h 00Cures & CapitalMike Rea on why pharma struggles with innovation - and how to fix itIn this episode, Mike Rea - CEO, IDEA Pharma - takes us on a journey through innovation and value creation in pharma. It is not all roses!He shares his candid views on what the pharmaceutical industry needs to do better to be less confused about innovation.Mike Rea also explains the importance of getting the definition of innovation right in drug development. Early commercial involvement in drug R&D is another key pillar in his drug innovation philosophy.We also get to discuss organizational design and team size conducive to unlocking pharma's...
2025-02-181h 08Cures & CapitalKelvin Stott on what it takes to fix pharma's broken business modelIn this episode, Kelvin Stott talks about why might be pharma's business model broken and how can it be fixed, the declining ROI on drug R&D, better R&D portfolio decision making, raising the bar in pharma/biotech innovation and more. Kelvin Stott has over 20 years of diverse leadership experience in pharma R&D strategy and operations, drug discovery and development, portfolio management, strategy consulting, biotech start-ups and venture capital. Currently, he is the Founder and CEO of Amporin Pharmaceuticals.If you want to connect with us:Linkedin: https://www.linkedin.com/company/c...
2025-02-021h 00Cures & CapitalJack Scannell on drug R&D decision-making: The value of getting it rightIn this episode, Dr. Jack Scannell delves into topics such as R&D productivity, decision-making, model validity, and more.If you're looking to deepen your understanding of these areas, there's no better guide than Jack.Jack brings a deep and holistic understanding of the biotech and pharma industry, having held a variety of roles—including being a neuroscientist, strategy consultant, investment analyst, and now the CEO of Etheros Pharmaceuticals.Chapters:00:00 Intro02:08 Guest introduction - Dr. Jack Scannell05:46 R&D productivity from past to present to future34:00 Decision making, model va...
2025-01-211h 18Cures & CapitalCures & Capital: Trailer EpisodeEPISODE 1 - Cures & Capital: Trailer EpisodeIn this episode, we introduce the scope and mission of the podcast.Our focus with Cures & Capital is the intersection between drug R&D and finance. Hosts: Martin Slezak & Simon Birksø.Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.
2025-01-1103 min
Totally Preventable100th Episode
Colby MartinPaws and Recovery – pawsandrecovery.com
Susan MaresettiBe Smart for Kits – besmartforkids.org
Stacy DuboisGet Rooted Recovery – getrooted.us
Elizabeth McGannGirls on the Run – GOTRRI.org
Heidi List-MurphyThe List Academy of Music – Thelistacademyofmusic.org
Shannon Dos SantosThe Village RI – RIvillage.org
Lisa Bigney and Halley LavensteinRI Tutorial and Education Services – RItutorial.org
Erica HansonRIDOH Community Health Network – health.ri.gov/programs/
Sam SlezakButler, Memory a...
2024-12-0632 min
Podcast ConversacinesConversacines 194 - Esta tierra es mía (Jean Renoir 1943)Albert Lory (Charles Laughton) es un profesor de escuela en una ciudad de un país indeterminado ocupado por el ejército Nazi durante la II Guerra Mundial. Enamorado de su compañera de trabajo y vecina, la también profesora Louise Martin (Maureen O’Hara), Albert se siente frustrado al ser incapaz de declararse por su carácter acobardado. Esta cobardía es también motivo de burla de sus propios alumnos. Para colmo, Louise mantiene una relación con un hombre llamado George Lambert (George Sanders). Cuando una serie de acontecimientos provocan que Albert sea detenido por los soldados a...
2024-06-2255 min
Major League Eventing PodcastBradley Champagne - Canadian 3* EventerKaren and Robby get to know Canadian Eventer, Bradley Champagne. Brad is a previous guest from episode #25 with the Windurra Crew. Brad shares his story of growing up in Canada and spending a winter in Ocala, Fl with Karl Slezak. Brad eventually became a rider for Boyd Martin and found his calling of breaking and training the young horses and getting them to the YEH Championships. Brad has gone to Ireland for the 2nd year in a row and brought back a couple nice horses through the Excel Star Sporthorses. PC: Amy DragooFollow Brad's j...
2024-01-0343 min
The Clyborn and Chloe ShowThe Clyborn and Chloe Show - episode 616Greetings Earth Dwellers! This week's show finds Clyborn & Chloe both at Clyborn's bungalow in San Francisco, CA. They welcome into the studio the kings of WNY ambient music...Cosmic Oases! This band consists of Barry DiGregorio, John Martini and Bruce Blair. They bring in with them their new CD that was just released last week. It's entitled Psychedelic Amusement Park. They sit on the "Couch Of Truth" and spill the beans about their past, present and future in the music business. They also play tunes from their new album. Other WNY bands/artists feaured in this show are as follows...
2023-07-012h 21Daytime ConfidentialDC #374: ABC Casting BloodbathOn today's ABC episode of Daytime Confidential Luke and Tina are joined by Eye on Soap's Belinda and Karen from Wubs.net to discuss the latest in All My Children, General Hospital and One Life to Live news including...Greenlee's funeral on All My Children at the Fusion bar. Ricky Paull Goldin's Jake Martin. Is this David Hayward the real David Hayward? Rumors that the Cortlandt mansion is burning down.General Hospital's possible casting bloodbath. What this means for Leslie Charleson, Megan Ward, Greg Vaughan, Rebecca Herbst and Rick Hearst. Constance Towers is returning as Helena...
2009-03-1140 min